Viewing Study NCT04344158

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-05-15 @ 6:35 PM
Study NCT ID: NCT04344158
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-20
First Post: 2020-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Hepatocellular Carcinoma (HCC) View
Keywords: